Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors

Keyphrases

• Alexa Fluor 488 11%
• Antitumor Efficacy 11%
• Apoptosis 11%
• Biodistribution 11%
• Circulation Half-life 11%
• Cytotoxic Drugs 11%
• Doxorubicin 100%
• Drug Accumulation 11%
• Drug Delivery 11%
• Drug Deposition 11%
• Drug Retention 11%
• Encapsulated Drugs 11%
• Enhanced Cytotoxicity 11%
• Highly Selective 11%
• In Vivo Screening 11%
• Liposome-encapsulated 100%
• Liposomes 11%
• Molecular Targets 11%
• Near-infrared Imaging 11%
• Necrosis 11%
• Pegylated Liposomal Doxorubicin 11%
• Pharmacokinetic Study 11%
• Random Peptide Library 11%
• Selective Binding 11%
• Systemic Toxicity 11%
• Targeted Liposomes 33%
• Tumor 100%
• Tumor Blood Vessels 11%
• Tumor Cell Proliferation 11%
• Tumor Cells 11%
• Tumor Growth Control 22%
• Tumor Growth Rate 11%
• Tumor-bearing Mice 11%
• Tumor-targeted Delivery 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Bacteriophage 5%
• Bioavailability 5%
• Biodistribution 5%
• Cytotoxic Agent 5%
• Cytotoxicity 5%
• Doxorubicin 100%
• Liposome 100%
• Liposome Targeting 17%
• Molecular Target 5%
• Mouse 5%
• Necrosis 5%
• Neoplasm 100%
• Pharmacokinetics 5%
• Targeted Drug Delivery 5%
• Tumor Growth 17%
• Vascular Tumor 5%